Analyst Ratings for CorMedix (CRMD)
CRMD Rating Summary
CRMD Price Target Summary
- Highest: $18.00 (Citizens)
- Lowest: $13.00 (H.C. Wainwright)
- Average: $14.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.50 (+124.5%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$14.50 (+124.5%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/20/2025 | D. Boral Capital | Jason Kolbert | Upgrade | Buy (Hold) |
14.00 (N/A) |
10.18 (6.46) |
-36.54% | Details |
| 6/30/2025 | H.C. Wainwright » Updated 1/23/2026 |
Brandon Folkes | New Coverage | Buy (N/A) |
13.00 (18.00) |
12.50 (6.46) |
-48.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
